XENETIC BIOSCIENCES, INC. Operating Leases, Future Minimum Payments, Due in Five Years
XENETIC BIOSCIENCES, INC. (XBIO) had Operating Leases, Future Minimum Payments, Due in Five Years of $8.91 thousand as of 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2015-07-20
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $8.91K.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $106.56K.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2014-12-31 | $8.91K 10-K · filed 2015-04-15 |
| 2013-12-31 | $106.56K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |